Clinical Trials Logo

Clinical Trial Summary

Macular hole is a hole formation which takes place in the center of the retina. Such a hole needs surgical steps in order to close. Closure of the macular hole will lead to a substantially improvement of vision in most cases. Following macular hole surgery a tamponade of intraocular gas is normally injected in order to keep the macula dry for the postoperative period. Postoperative face down position for a week was earlier standard. Several authors report of good closure rates with both air tamponade or lack of face down positioning. In this study standard pars plana vitrectomy with peeling of the internal limiting membrane (ILM) will be performed. The gas tamponade will be replaced by air. Postoperative face down positioning will not be used.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01680068
Study type Interventional
Source Helse Stavanger HF
Contact
Status Completed
Phase N/A
Start date September 2012
Completion date October 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03465865 - Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
Active, not recruiting NCT01969929 - Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy N/A
Completed NCT02011165 - An Objective Evaluation of Postoperative Positioning in Macular Hole Surgery N/A
Completed NCT01627977 - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy Phase 3
Completed NCT00408720 - Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies N/A
Completed NCT00555269 - Membrane Blue Versus Infracyanine Green N/A
Terminated NCT02295943 - Objective Evaluation of Postoperative Positioning in Macular Hole Surgery N/A
Terminated NCT00333060 - Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal Phase 2
Completed NCT01083056 - Observational Study - ILM Peeling N/A
Completed NCT02930369 - Effects of Different Area of Internal Limiting Membrane Peeling (ILM) Peeling on Anatomical Outcomes in Macular Hole Surgery Phase 4
Recruiting NCT02067013 - Analysis of Aqueous and Vitreous Humor Phase 2
Completed NCT01959776 - Asymmetrical Recovery of Cone Outer Segment Tips and Foveal Displacement After Macular Hole Surgery N/A
Completed NCT05710458 - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter N/A
Recruiting NCT02423213 - DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Terminated NCT01820520 - Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery Phase 3
Completed NCT01509092 - Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole N/A
Recruiting NCT01083004 - Brilliant Blue Versus Indocyanine Green Phase 3
Completed NCT01069029 - Combined Versus Successive Macular Hole and Cataract Surgery N/A
Completed NCT00190190 - Internal Limiting Membrane Peeling for Large Macular Holes N/A
Completed NCT00737074 - Macular Hole in Diabetic Retinopathy N/A